Results 131 to 140 of about 280,195 (357)

CLINICAL, LABORATORY AND X-RAY PECULIARITIES OF INVASIVE ASPERGILLOSIS IN B-CELLULAR LYMPHOMS PATIENTS

Медицинский совет, 2017
The study included 108 patients with B-cell lymphoma which had complication with invasive aspergillosis, 57 patients with Hodgkin lymphoma (HL) and 51 patients with non-Hodgkin lymphoma (NHL).
Y. A. CHUDINOVSKIKH, T. Y. SEMIGLAZOVA, N. N. KLIMKO, A. A. BARCHUK, O. V. SHADRIVOVA, E. V. FROLOVA, T. S. BOGOMOLOVA, S. M. IGNATIEVA, S. M. ALEXEEV, I. S. ZYUZGIN, L. V. FILATOVA, V. V. SEMIGLAZOV, E. V. KHARCHENKO, A. B. KOSICHKINA, M. S. MOTALKINA, U. B. KHADONOV, Y. A. OLEYNIK, A. A. ZVERKOVA, I. V. OSHMATOVA, A. Y. SUBORA, S. A. SHALAEV, P. S. SHILO, S. M. ALEXEEV   +22 more
doaj   +1 more source

Risk of Non–Hodgkin Lymphoma Associated with Germline Variation in Genes that Regulate the Cell Cycle, Apoptosis, and Lymphocyte Development [PDF]

, 2009
Lindsay M. Morton, Mark P. Purdue, Tongzhang Zheng, Sophia Wang, Bruce K. Armstrong, Yawei Zhang, Idan Menashe, Nilanjan Chatterjee, Scott Davis, Qing Lan, Claire M. Vajdic, Richard K. Severson, Theodore R. Holford, Anne Kricker, James R. Cerhan, Brian P. Leaderer, Andrew E. Grulich, Meredith Yeager, Wendy Cozen, Shelia Hoar Zahm, Stephen J. Chanock, Nathaniel Rothman, Patricia Hartge   +22 more
openalex   +1 more source

A causal inference framework to compare the effectiveness of life‐sustaining ICU therapies—using the example of cancer patients with sepsis

International Journal of Cancer, EarlyView.
What's New? Rising cancer incidence in the United States is associated with an increased demand on intensive care units (ICUs). Critically ill cancer patients, however, often rely on life‐sustaining therapies, which are linked to greater ICU mortality.
João Matos, Tristan Struja, Naira Link Woite, David Restrepo, Andre Kurepa Waschka, Leo A. Celi, Christopher M. Sauer   +6 more
wiley   +1 more source

Clinicopathological characteristics of T-cell non-Hodgkin lymphoma arising in patients with immunodeficiencies: a single-center case series of 25 patients and a review of the literature

Haematologica, 2018
Although it is known that B-cell lymphomas occur more frequently in immunocompromised patients, thus far such an association has not been clearly established for T-cell lymphomas.
Marieke L. Nijland, Lianne Koens, Steven T. Pals, Ineke J.M. ten Berge, Frederike J. Bemelman, Marie José Kersten   +5 more
doaj   +1 more source

Sustained delivery and molecular targeting of a therapeutic monoclonal antibody to metastases in the central nervous system of mice. [PDF]

, 2019
Approximately 15-40% of all cancers develop metastases in the central nervous system (CNS), yet few therapeutic options exist to treat them. Cancer therapies based on monoclonal antibodies are widely successful, yet have limited efficacy against CNS ...
Chen, Irvin SY, Guan, Xin, Kamata, Masakazu, Kranz, Emiko, Lee, YooJin, Liu, Chaoyong, Liu, Yang, Lu, Yunfeng, Martinez-Maza, Otoniel, Qin, Meng, Sun, Guibo, Sun, Xiaobo, Vinters, Harry V, Wang, Lan, Wen, Jing, Widney, Daniel, Wu, Di, Xu, Duo   +17 more
core  

Assessment of the Hematopoietic Cell Transplantation Comorbidity Index in Non-Hodgkin Lymphoma Patients Receiving Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation [PDF]

, 2009
Seth M. Pollack, Seth M. Steinberg, Jeanne Odom, Robert M. Dean, Daniel H. Fowler, Michael Bishop   +5 more
openalex   +1 more source

Tumor‐infiltrating B cells participate in shaping the immunosuppressive microenvironment in solid tumors

International Journal of Cancer, EarlyView.
Abstract Tumor‐infiltrating B cells (TIBs) exhibit dual roles in the tumor microenvironment (TME) of solid tumors. While they can enhance anti‐tumor immunity through antibody production and immune activation, certain subsets—such as regulatory B cells (Bregs) and immunosuppressive plasma cells—contribute to immune evasion by secreting inhibitory ...
Zhitong Li, Ziyang Shen, Yuxiang Sun, Pengcheng Zhu, Tongyan Liu, Rong Yin   +5 more
wiley   +1 more source

DNA methyltransferase inhibitors in hematological malignancies and solid tumors

International Journal of Cancer, EarlyView.
Abstract Epigenetic modifications such as DNA methylation play a fundamental role in oncogenesis and the progression of neoplasms neoplasias. DNA methyltransferase inhibitors (DNMTi) constitute a family of therapeutic agents that impede the methylation at the 5‐position on cytosine nucleotides, thereby modulating the epigenetic regulation of tumor ...
Valentin Wenger, Guillermo Garcia‐Manero, Robert Zeiser, Michael Lübbert   +3 more
wiley   +1 more source

Complete remission with ibrutinib after allogeneic stem cell transplant for central nervous system relapse of mantle cell lymphoma: A case report and literature review

Clinical Case Reports, 2019
Central nervous system (CNS)‐relapsed mantle cell lymphoma (MCL) is a rare, aggressive non‐Hodgkin lymphoma without a standard treatment. Ibrutinib has shown promising results for inducing remission in other non‐Hodgkin lymphomas and may be considered as
Jessica D. Rich, Stephen M. Clark, Yuri Fedoriw, Valerie Jewells, William Wood, Christopher Dittus   +5 more
doaj   +1 more source

R‐GDP SCHEDULE IN PATIENTS WITH REFRACTORY OR RELAPSED B‐CELL NON‐HODGKIN LYMPHOMA (B‐NHL) [PDF]

, 2021
Jordi Rovira, Eva González‐Barca, Juan‐Manuel Sancho, Nicholas Kelleher, M. Rodríguez, María Laura Fox, Rocío Parody, Sara Salvador Martín, Ana Vicent, Jauri Villarroel, Carlos De la Fuente, Josep‐María Ribera, Anna Sureda, Lourdes Escoda   +13 more
openalex   +1 more source